Furthermore, 2 Hz EA treatment at ST36, and TRPV1 gene deletion, can regulate the protein modifications observed in CPDC and subsequently regulate the affiliated symptoms of chronic pain and depression via these nociceptors and related downstream molecules in the cerebellum lobules VI, VII, and VIII (Figure 7). This evidence concerns the gene TRPV1 and depressive symptom measurement.